Growth in Gene and Cell Therapy Trials According to the American Society of Gene & Cell Therapy (ASGCT)-Citeline Q1 2025 report, the combined gene, cell and RNA therapy pipeline featured 4,418 active programs, including 2,155 gene therapies and 966 non-genetically modified cell therapies with 79 new gene therapy trials (57% in oncology) and 27 new cell therapy trials (74% in non-oncology) initiated that quarter
Evidence from a Cochrane review suggests that high-dose oral therapy can be as effective as intramuscular treatment for many individuals
the fosgonimeton LIFT-AD failure and the pro-proliferative c-Met concern and why sleep, exercise and stress control come first, a studied adaptogen is a considered option, and an unproven peptide is no option at all
Most claims are recycled from forums, anti-aging clinics, or anecdotal reviews. Is there potential
Actually helps with my energy levels and appetite curving
Curr Med Chem 19: 126132